By SYLUM Recently, Sylum announced the global launch of its breakthrough product, Regetting Regenerating Capsule (Regetting-18), developed with third-generation medical-grade anti-aging technology. This product targets mitochondrial repair and regeneration of high-energy mitochondria, innovatively realizing a comprehensive “damage clearance – youthful regeneration – functional remodeling” health management chain, providing a brand-new solution in the field of anti-aging.
With the advancement of modern scientific research into the mechanisms of aging, mitochondria—known as the “powerhouses of the cell”—have been proven to directly impact human health and longevity through their functional status. Healthy mitochondria can efficiently generate energy while minimizing the production of toxic free radicals. In contrast, damaged mitochondria result in decreased energy output and the accumulation of toxins, thereby triggering aging and leading to seven major health issues, including cancer, metabolic disorders, and neurodegenerative diseases. Studies show that mitochondrial damage in the human body intensifies annually from the age of 25, reaching a damage rate of 20% by age 35, rising to 30% by age 45, and surpassing 40% after age 55, making it a key factor accelerating aging and the onset of disease.
However, although mainstream anti-aging methods are widely used today, they have significant limitations. Traditional oral supplements, for example, typically contain single ingredients (such as individual antioxidants) and lack targeting capability, resulting in an actual absorption rate of less than 10% and making it difficult to effectively act on mitochondria—the critical target in aging. While dietary interventions and exercise can slow the aging process, they lack the ability to reverse accumulated mitochondrial damage and the decline in organ function. Against this backdrop, Regetting-18 Capsules are developed based on the scientific consensus that “mitochondria determine physiological age,” and for the first time introduce a “precision anti-aging three-step approach.” This technology pathway targets and activates microcirculation to clear senescent cells and free radical toxins, uses nutrient reperfusion to protect and repair damaged organs, and ultimately restarts mitochondrial function and regenerates high-energy mitochondria, systematically reversing the aging process.
As the world’s first medical-grade anti-aging product to integrate a dual mechanism of “clearance and regeneration,” Regetting-18 Capsules derive their core competitiveness from two innovative ingredients—GMI Ganoderma Microsporum Protein Peptide Mitochondrial Autophagy Factor and REGETTING-18 CP Mitochondrial Regeneration Factor. GMI Ganoderma Microsporum Protein Peptide is a fungal immunomodulatory protein that has been validated in Phase III anti-cancer clinical trials. It works by precisely clearing damaged mitochondria through activation of cellular autophagy mechanisms, thereby repairing organ function. REGETTING-18 CP, jointly developed by Sylum and the Davit Precision Nutrition Research Institute, features a proprietary formula that combines rare ginsenosides, spermidine, and monotropein, among other ingredients, significantly increasing both the quantity and performance of mitochondria while also boosting telomerase activity and telomere length, thus overall extending the expected healthy lifespan.
The technological breakthrough of Regetting-18 Capsules has garnered high recognition from the global scientific community. Thirty-six functional patents cover key effects such as immune enhancement, promotion of wound healing, inhibition of fibrosis, and cancer treatment, while thirteen international invention gold medals further attest to its technological leadership. Multicenter double-blind clinical trials have further validated its efficacy: subjects experienced a mitochondrial membrane potential recovery rate of 82.3%, a 216% increase in cellular ATP production, a 38% improvement in liver detoxification efficiency, and a 29% boost in myocardial cell vitality.
Sylum has always been committed to transforming cutting-edge biotechnology into accessible health solutions. The launch of the Regetting-18 Capsule is an important step in fulfilling its mission of “extending healthy life expectancy.” Going forward, the company will continue to focus on full-lifecycle health management and drive anti-aging technologies from the laboratory into everyday life.
The Regetting-18 Capsule revitalizes cells and sustains life through the power of science!